Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05565703 · ClinicalTrials.gov registry record · NA
The Use of PARO to Decrease Agitation in Persons With Dementia and/or Delirium
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT05565703: Completed NA study, sponsored by University of Pennsylvania.
NCT05565703 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05565703, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
This Clinical trial tests the efficacy of using the PARO robotic seal to decrease agitation in hospitalized older adults with dementia and/or delirium. This clinical trial also tests the efficacy of the cleaning protocol for the robot. This randomized control trial includes a one hour interaction with the PARO robot two days in a row compared to an attention control with the researcher sitting with the participant in their room for one hour two days in a row. The outcomes being evaluated include both qualitative and quantitative data. Qualitative data from videotaped interactions with the persons interacting with the PARO Robot include episodes of agitation, and emotional responses to the robot via facial expressions. The quantitative outcomes include the Agitation, use of 1:1 sitters, use of psychoactive medications and length of stay.
Interventions
- OTHER Attention Control
- OTHER PARO Robotic Seal Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2018-10-30 |
| Est. Completion | 2023-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05565703
The ClinicalTrials.gov registry entry for NCT05565703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT05565703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05565703 about?
NCT05565703 is a clinical study titled "The Use of PARO to Decrease Agitation in Persons With Dementia and/or Delirium". This Clinical trial tests the efficacy of using the PARO robotic seal to decrease agitation in hospitalized older adults with dementia and/or delirium. This clinical trial also tests the efficacy of the cleaning protocol for the robot. This randomized control trial includes a one hour interaction wi...
What is the current status of trial NCT05565703?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2018-10-30. Estimated completion is 2023-10-30.
What interventions are being tested in trial NCT05565703?
The interventions under investigation include: Attention Control (OTHER), PARO Robotic Seal Intervention (OTHER).
Who is sponsoring clinical trial NCT05565703?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.